Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
about
Non-xanthine heterocycles: activity as antagonists of A1- and A2-adenosine receptorsLeishmania metacyclogenesis is promoted in the absence of purinesAdenosine receptor blockade reverses hypophagia and enhances locomotor activity of dopamine-deficient miceAdenosine A(1) and prostaglandin E receptor 3 receptors mediate global airway contraction after local epithelial injury.Failure of CGS15943A to block the hypotensive action of agonists acting at the adenosine A3 receptor.Extracellular Adenosine Protects against Streptococcus pneumoniae Lung Infection by Regulating Pulmonary Neutrophil RecruitmentThe in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonistCharacterization of human striatal A2-adenosine receptors using radioligand binding and photoaffinity labelingFurther characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranesAdenosine receptor-mediated contraction and relaxation of guinea-pig isolated tracheal smooth muscle: effects of adenosine antagonistsFurther investigations into adenosine A1 receptor-mediated contraction in rat colonic muscularis mucosae and its augmentation by certain alkylxanthine antagonists.Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models
P2860
Q24599034-799FFABE-5C85-4E68-BEE7-B0AE0A69A910Q27305338-6CDF13A3-CAF8-4470-86C4-8A5CB107479BQ28593583-770BDE14-1A8D-42D5-9A49-04A0FBDC03DFQ30537881-22EF5954-DEB1-44D3-A34D-AD8A953D690FQ34793606-943199A0-4E8D-4EC4-9F2C-19332FDDA808Q35757502-EE68990A-7EEF-4733-932C-7AEDA3804FF7Q35872902-830323E9-CD98-4CD3-92A8-9BDF540967D6Q36194316-15581704-C896-448F-90F2-3B8BA08B99C9Q42161522-90BC81F9-7C7A-44F4-B10F-375301065F01Q42196443-4E7080ED-9C6B-4340-83A3-372128DD6F28Q42201162-6980E12B-6A88-4159-8407-C8DF96253689Q42257939-63F1588D-5D05-446F-8BBB-9D18CD310CE7Q42700371-F7DBE359-3E2D-49D4-8FCC-CB71CCFF4EB7
P2860
Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
description
1987 nî lūn-bûn
@nan
1987 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Biochemical characterization o ...... xanthine adenosine antagonist.
@ast
Biochemical characterization o ...... xanthine adenosine antagonist.
@en
Biochemical characterization o ...... xanthine adenosine antagonist.
@nl
type
label
Biochemical characterization o ...... xanthine adenosine antagonist.
@ast
Biochemical characterization o ...... xanthine adenosine antagonist.
@en
Biochemical characterization o ...... xanthine adenosine antagonist.
@nl
prefLabel
Biochemical characterization o ...... xanthine adenosine antagonist.
@ast
Biochemical characterization o ...... xanthine adenosine antagonist.
@en
Biochemical characterization o ...... xanthine adenosine antagonist.
@nl
P2093
P1476
Biochemical characterization o ...... xanthine adenosine antagonist.
@en
P2093
Braunwalder A
Psychoyos S
Williams M
P304
P407
P577
1987-05-01T00:00:00Z